Background: Atopic dermatitis (AD) is one of the most common skin diseases with a
| INTRODUC TI ON
Atopic dermatitis (AD) is a common eczematous pruritic disease with an onset at an early age, affecting up to 30% of children in the Western world. Etiology of AD is multifactorial including genetic predisposition, environmental factors, and immune status, leading to a high complexity in clinical presentation.
1-3 Predisposing genetic factors for the development of AD include mutations in genes affecting the integrity of the skin barrier, such as mattrin (TMEM79) and filaggrin (filament aggregation protein, FLG). [4] [5] [6] Filaggrin mutations were found in 30% of AD patients in Poland, 7 China (26.0%), 8 and Korea (15.7%), 9 while healthy individuals had none. Importantly, filaggrin expression is downregulated in AD patients independent of their FLG genotype as a consequence of increased type 2 cytokines contributing to the aggravation of disease.
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We have previously separated and described the two mutated genes-Tmem79/mattrin and filaggrin-leading to the allergic skin phenotype of flaky tail mice. 5, 11 Single mutant mice both have a defective skin barrier, and both spontaneously develop AD-like inflammation.
Pathogenesis in Tmem79 ft/ft mice is dependent on adaptive immunity, while Flg ft/ft mice develop dermatitis through innate immune cells.
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However, the mechanisms underlying inflammation are unclear.
Results: Wild-type and Flg ft/ft mice significantly differ in their microbiome composition. Furthermore, mutant mice do not develop skin inflammation under germ-free conditions. ILC2 deficiency did not ameliorate chronic dermatitis in Flg ft/ft mice, which was also independent of IL-4, IL-5, IL-9, IL-13, IL-17A, and IL-22. Inflammation was independent of NLRP3 inflammasome activation but required IL-1β and IL-1R1-signaling. Mechanistically, IL-1β promoted hyperactivation of IL-1R1-expressing mast cells.
Treatment with anti-IL-1β-antibody alleviated dermatitis exacerbation, while antibiotic intervention ameliorated dermatitis in neonatal mice but not in adults with established inflammation.
Conclusions: In summary, we identified a critical role for the microbiome and IL-1β mediating chronic inflammation in mice with an impaired skin barrier.
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G R A P H I C A L A B S T R A C T
Filaggrin deficiency leads to skin dysbiosis early after birth altering adult immune responses, while mice raised under germ-free conditions remain disease-free. NLR Family Pyrin Domain Containing 3-independent processing of IL-1 in the skin promotes atopic dermatitis (AD)-like ILC2-independent inflammation. IL-1 deficiency or targeting IL-1 by monoclonal antibodies ameliorates dermatitis. IL-1R1-expressing dermal mast cells are key responders to IL-1, acquire a hyperactive phenotype, and promote AD-like inflammation.
As an atopic disorder, AD is classically considered a type 2-driven immunopathology involving type 2 T helper (Th2) cells, interleukin 
36
In the present study, we set out to investigate the mechanisms underlying AD-like inflammation in Flg ft/ft mice. We discovered that ILC2-while required for acute MC903-induced dermatitis-were dispensable for spontaneous AD-like inflammation in Flg ft/ft mice with an impaired skin barrier. Instead, the development of skin inflammation was dependent on an interplay between microbiota, IL-1β, and mast cells.
| MATERIAL AND ME THODS

| Mice
The following mice were backcrossed onto the Flg ft/ft (initially isolated from flaky tail mice, JR#9078, Jackson Laboratories, Bar Harbor, ME 
| Scoring of skin inflammation
Severity of skin inflammation was clinically scored (total range: 0-12)
by macroscopic diagnostic criteria as previously described. 5 The total score is the sum of individual scores ranging from 0 to 3 (0, none; 1, mild; 2, moderate; 3, severe) that were applied to edema, erythema, scaling, and erosion.
| Preparation of bone marrow-derived mast cells (BMMC) and stimulation
Bone marrow was isolated from the femur and tibia of donor mice and 
| Microbiome analysis
Skin microbiome samples were acquired by exposing sterile swabs to the ear skin of Flg ft/ft and wild-type mice, as previously published. 56 Mice were kept in the same or adjacent cages, looked after by the same person using the same products. Same surface area was sampled for all age-and sex-matched mice. Expression of genes associated with AD (Il33, Il1a, Il1b) was significantly altered in the absence of microbiota ( Figure 2I ). Importantly, However, the cellular events leading up to AD development in this mouse model remain unclear.
| Atopic dermatitis is independent of group 2 innate lymphoid cells
The appearance and severity of dermatitis in Flg ft/ft mice is dependent on cells of the innate immune system ( Figure 3A) 11 with a significant increase in dermal ILC2 numbers in Flg ft/ft mice ( Figure 1F ). Therefore, Figure 3C ). These data from three separate and distinct models of ILC2 deficiency led us to conclude that ILC2 were dispensable for skin inflammation in this spontaneous and chronic model of AD-like inflammation in mice with a defective skin barrier.
| Group 2 innate lymphoid cells promote acute skin inflammation
Daily application of MC903 elicits acute AD-like skin inflammation 28 ( Figure 3D ). We, and others, have previously shown using antibody-mediated depletion models as well as bone marrow chimeric mice that development of MC903-elicited skin inflammation is dependent on ILC2. 25, 27 Indeed, using ILC2-deficient Rora fl/sg Il7ra
Cre/+ mice, we could confirm that ear swelling was ameliorated in acute dermatitis ( Figure 3D ). As expected, ILC2 were not present in the IL-1β requires processing by the NLRP3 inflammasome to be cleaved from pro-IL-1β to become bioactive IL-1β. We generated 
F I G U R E 3 Dermatitis in
| Dermal mast cells promote inflammation in mice with impaired skin barrier
A study in mice with NLRP3-dependent skin inflammation analyzed the interplay between microbiota, TNFα, and IL-1β and demonstrated a critical role for mast cells in skin inflammation. Figure 6D ). Indeed, when we induced inflammation in these mice using MC903, IL-1β-responsive mast cells were sufficient to aggravate inflammation ( Figure 6D ). Interestingly, germ-free Flg ft/ft mice had significantly decreased serum levels of IgE compared to their SPF counterparts ( Figure 2H ) and-lacking the IgE-mediated activation of mast cells-also showed decreased levels of MCP-1 ( Figure 6F ). Importantly, GF mice showed reduced expression of IL-1β further reducing activation of mast cells ( Figure 2I ).
These data indicate that IL-1β-mediated hyperactivation of mast cells contributes significantly to dermatitis in Flg ft/ft mice.
| D ISCUSS I ON
In the present study, we have shown that the development of skin inflammation in Flg ft/ft mice is independent of group 2 innate lymphoid cells but requires an interplay between the microbiome, IL-1β, Treatment with the NLRP3-inflammasome inhibitor MCC950
did not ameliorate inflammation in our multifactorial model of AD when we triggered an acute inflammatory response with MC903.
Furthermore, inflammation was unaltered in NLRP3-deficient, ASCdeficient, and AIM2-deficient Flg ft/ft mice. Therefore, IL-1β processing occurs independent of the NLRP1, NLRP3, NLRP6, and AIM2
inflammasome. To date, we cannot rule out a role for the NLRC4 inflammasome (or NAIP-NLRC4) that can directly recruit caspase-1.
In a recent study, NLRC4 was found in the scale extracts of psoriasis patients; however, no inflammasome components (including NLRC4)
were found in atopic dermatitis patients. 89 Inflammasome-independent processing of IL-1β has been observed in a variety of settings (reviewed in 90 ). In particular, neutrophil-and mast cell-derived proteases play prominent roles in the extracellular processing of IL-1-family cytokines, 91, 92 with human mast cell protease 1 shown to process pro-IL-1. 93 Increased mast cell chymase activity may therefore contribute to IL-1β maturation in the Flg ft/ft model; however, further investigations are required to fully understand the role of mast cell proteases in AD.
Skin microbiome sequencing revealed a shift toward pathogenic staphylococci, which has been reported in AD patients.
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While the microbiota in flaky tail mice induced IL-17A-mediated neutrophilia, we could show that in Flg ft/ft mice IL-17A was redundant. 33 Indeed, IL-17A-mediated inflammation is observed in In summary, we revealed a critical role of IL-1β in the initiation and maintenance of skin inflammation in a mutant mouse model of defective skin barrier. Further investigations will be required to assess the contribution of IL-1β-responsive mast cells, as well as roles of the integrity of the skin barrier and interplay of the microbiome, in the generation of inflammation in AD patients. These endeavors will lead to the development of novel management options for children suffering from AD.
